JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY – Trademark Portfolio
Entity Type: 99
JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MYLICON. The owner is based in FORT WASHINGTON, PA.
CAMP HILL RD
FORT WASHINGTON, PA 19034
Showing of trademarks Trademarks
Trademark Classifications
JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY have?
JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY file in?
JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY's most well-known trademarks?
JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY's registered trademark portfolio includes well-known marks such as MYLICON. These are among 1 currently registered trademark in the portfolio.
What is JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY's trademark registration success rate?
JOHNSON & JOHNSON*MERCK CONSUMER PHARMACEAUTICALS COMPANY has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.